Home > Healthcare > Medical Services > Clinical Trial Equipment & Ancillary Solutions Market

Clinical Trial Equipment & Ancillary Solutions Market Share

Report ID: GMI9268
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Clinical Trial Equipment & Ancillary Solutions Market Share

The market for clinical trial equipment and ancillary solutions is highly competitive, with key players vying for market share through innovation and strategic partnerships. The major companies are prioritizing comprehensive supply chain and logistics services, while startups and niche companies are enhancing competitiveness with specialized ancillary solutions and technologies, shaping a dynamic market landscape.

Clinical Trial Equipment & Ancillary Solutions Market Companies

Some of the prominent players operating in the clinical trial equipment & ancillary solutions industry include:

Andwin Scientific
Ancillare, LP.
AXELERIST FINANCIAL
Biocair
ICON plc
Imperial CRS, LLC.
Marken
MESM UK.
Myonex
NUVISAN
Oximio
Parexel International (MA) Corporation
Quipment SAS
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Clinical trial equipment & ancillary solutions industry size recorded USD 1.5 billion in 2023 and will expand at a 7.5% CAGR between 2024 and 2032, driven by the rising complexity of clinical trials, the globalization of clinical research, and advancements in technology.

The diagnostic equipment segment in the market will reach USD 1.1 billion by 2032, owing to increasing emphasis on precision medicine and personalized healthcare.

North America clinical trial equipment & ancillary solutions industry size was USD 730.7 million in 2023, primarily due to its advanced healthcare infrastructure, robust research and development activities, and supportive regulatory framework.

Key players operating in the clinical trial equipment & ancillary solutions industry are Ancillare, LP., Axelerist Financial, Biocair, ICON plc, Imperial CRS, LLC, Marken, MESM UK., Myonex, Nuvisan, Oximio, Parexel International (MA) Corporation, Quipment SAS, and Thermo Fisher Scientific Inc.